NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

4831. SAMHSA is missing opportunities to better monitor access to medication-assisted treatment through the buprenorphine waiver program

4832. Concerns persist about opioid overdoses and Medicare beneficiaries’ access to treatment and overdose-reversal drugs

4833. Characteristics of separated children in ORR’s care: June 27, 2018–November 15, 2020

4834. Drug safety: FDA should take additional steps to improve its foreign inspection program : report to congressional requesters

4836. Some Medicare Advantage companies leveraged chart reviews and health risk assessments to disproportionately drive payments

4837. Hospitals reported that the COVID-19 pandemic has significantly strained health care delivery

4838. The role of clinical and cost information in Medicaid pharmacy benefit decisions: experience in seven states

4840. State options that expand access to Medicaid home and community-based services